Taylor Devices (TAYD) Competitors

Ekso Bionics (NASDAQ:EKSO) and Taylor Devices (NASDAQ:TAYD) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, risk, community ranking, valuation, media sentiment, analyst recommendations, dividends and earnings.

Does the media refer more to EKSO or TAYD?

In the previous week, Ekso Bionics had 4 more articles in the media than Taylor Devices. MarketBeat recorded 5 mentions for Ekso Bionics and 1 mentions for Taylor Devices. Ekso Bionics' average media sentiment score of 0.26 beat Taylor Devices' score of 0.00 indicating that Ekso Bionics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Ekso Bionics	0 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Taylor Devices	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Is EKSO or TAYD more profitable?

Taylor Devices has a net margin of 21.22% compared to Ekso Bionics' net margin of -62.95%. Taylor Devices' return on equity of 18.95% beat Ekso Bionics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ekso Bionics	-62.95%	-83.09%	-39.03%
Taylor Devices	21.22%	18.95%	16.28%

Do analysts recommend EKSO or TAYD?

Ekso Bionics presently has a consensus price target of $5.50, indicating a potential upside of 695.95%. Given Ekso Bionics' stronger consensus rating and higher probable upside, equities research analysts plainly believe Ekso Bionics is more favorable than Taylor Devices.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ekso Bionics	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
Taylor Devices	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Do insiders and institutionals hold more shares of EKSO or TAYD?

6.4% of Ekso Bionics shares are owned by institutional investors. Comparatively, 17.6% of Taylor Devices shares are owned by institutional investors. 6.1% of Ekso Bionics shares are owned by insiders. Comparatively, 7.8% of Taylor Devices shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Which has stronger earnings & valuation, EKSO or TAYD?

Taylor Devices has higher revenue and earnings than Ekso Bionics. Ekso Bionics is trading at a lower price-to-earnings ratio than Taylor Devices, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ekso Bionics	$17.68M	0.86	-$15.20M	-$0.65	-1.06
Taylor Devices	$46.28M	3.13	$9M	$2.90	16.00

Which has more volatility and risk, EKSO or TAYD?

Ekso Bionics has a beta of 1.47, meaning that its stock price is 47% more volatile than the S&P 500. Comparatively, Taylor Devices has a beta of 1.04, meaning that its stock price is 4% more volatile than the S&P 500.

Does the MarketBeat Community believe in EKSO or TAYD?

Ekso Bionics received 210 more outperform votes than Taylor Devices when rated by MarketBeat users. However, 70.44% of users gave Taylor Devices an outperform vote while only 55.71% of users gave Ekso Bionics an outperform vote.

Company	Underperform	Outperform
Ekso Bionics	Outperform Votes 322 55.71%	Underperform Votes 256 44.29%
Taylor Devices	Outperform Votes 112 70.44%	Underperform Votes 47 29.56%

Summary

Taylor Devices beats Ekso Bionics on 11 of the 18 factors compared between the two stocks.